Oct 2010 – March 2011
Companies are listed in alphabetical order
1 October 2010 – 30 March 2011
- Abbott Australasia
200k - Abbott Products (formally Solvay)
74k - Actelion 72k
- Alcon Pharmaceuticals 134k
- Allergan 36k
- AMGEN Australia 184k
- AstraZeneca 856k
- Baxter Healthcare 38k
- Bayer Australia 160k
- Biogen Idec Australia 142k
- Boehringer Ingelheim 322k
- Bristol-Myers Squibb Australia 73k
- Celgene Pty Ltd 296k
- CSL Limited 250k
- Eli Lilly Australia 475k
- Fresenius Kabi 67k
- Genzyme Australasia Pty Ltd 44k
- Gilead Sciences 55k
- GlaxoSmithKline Australia 437k
- iNova Pharmaceuticals 22k
- Invida Australia 11k
- Ipsen 55k
- Janssen 549k
- Lundbeck 37k
- Merck Serono 56k
- Merck Sharp & Dohme Australia 527k
- Mundipharma 88k
- Norgine 39k
- Novartis Pharmaceuticals 487k
- Novo Nordisk 190k
- Nycomed 118k
- Pfizer Australia 850k
- Roche Products 594k
- sanofi-aventis 93k
- Servier Laboratories 495k
- Shire Australia 44k
- Smith&Nephew 64k
- UCB Pharma 69k
Previous Educational Event Reports
Page updated: December 2011